Diploma PLC (LON:DPLM – Get Free Report) insider Wilson Ng acquired 424 shares of Diploma stock in a transaction dated Thursday, July 16th. The stock was purchased at an average price of GBX 7,066 per share, for a total transaction of £29,959.84.
Diploma Price Performance
Diploma stock opened at GBX 7,370 on Tuesday. The company has a current ratio of 2.06, a quick ratio of 0.80 and a debt-to-equity ratio of 47.65. The company has a fifty day simple moving average of GBX 6,979.65 and a 200-day simple moving average of GBX 6,257.69. The stock has a market cap of £9.88 billion, a P/E ratio of 52.34, a price-to-earnings-growth ratio of 2.82 and a beta of 0.92. Diploma PLC has a 12-month low of GBX 4,970 and a 12-month high of GBX 7,663.22.
Diploma (LON:DPLM – Get Free Report) last posted its earnings results on Tuesday, May 19th. The company reported GBX 74.70 EPS for the quarter. Diploma had a return on equity of 18.55% and a net margin of 9.42%.The firm had revenue of £851.10 million for the quarter. Equities analysts expect that Diploma PLC will post 163.7995512 EPS for the current fiscal year.
Analysts Set New Price Targets
Read Our Latest Report on Diploma
Key Diploma News
Here are the key news stories impacting Diploma this week:
- Positive Sentiment: Berenberg Bank reiterated its buy rating on Diploma PLC and lifted its price target to GBX 9,000, reinforcing a positive analyst view on the stock’s valuation and growth prospects. Broker views source
- Positive Sentiment: Several senior insiders bought shares, including Mandy Gradden (1,000 shares), Wilson Ng (424 shares), and Katie Bickerstaffe (multiple purchases), which investors often view as a sign management believes the stock is undervalued. TipRanks article
- Neutral Sentiment: An article highlighting Diploma as a potential long-term compounding stock added visibility, but it did not include new company-specific financial results or guidance. Yahoo Finance article
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Articles
- Five stocks we like better than Diploma
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
